Centre Léon Bérard-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

    Breast Cancer Research and Treatment, Vol. 169, Núm. 3, pp. 469-479